DEALS

Strategic Alliances Promote Test Access and Development

In the early months of 2017, the diagnostic industry has seen several strategic alliances develop. Among the most active companies in February so far is Quest Diagnostics which cut a deal to secure … [Read more...]

DEALS

Hologic Sells Blood Screening Business

During a slow month for diagnostic M&A activity, a noteworthy deal was Grifols's acquisition of Hologic's blood screening business. The acquired assets include a San Diego plant, development … [Read more...]

IMMIGRATION

Revised Travel Ban Issued

We recently outlined the major effects and the steps you can take to manage the impact of the travel ban executive order (See G2 Compliance Advisor, February 2017). Although that guidance was based on … [Read more...]

NEWSMAKERS

Veracyte Announces Big Developments

Veracyte, Inc. is a leader in developing noninvasive genomic diagnostic tests for lung cancer. And in February, Veracyte's share of this lucrative market grew significantly. Percepta Gets Thumbs Up … [Read more...]

INVESTMENTS

Inside the Lab Industry: Silicon Valley Bank Reports Steady 2016 Dx Investments, Declining Exits

Investments in the diagnostics and tools (Dx/Tools) sector remained steady in 2016, according to Silicon Valley Bank's annual report, Trends in Healthcare Investments and Exits 2017. The report's … [Read more...]

ENFORCEMENT

Enforcement E¢onomi¢$: ROI on US Fraud & Abuse Program Continues to Decline

While still profitable, the business of enforcing health care fraud laws has been providing the federal government a steadily declining return on investment (ROI) in recent years. This long-term trend … [Read more...]

NEWS

The 6 Things Labs Need to Know About the Trump Travel Ban

Although the first Trump travel ban didn't survive, a new version is already in the works. Although we don't yet know the details, the expectation is that the new travel ban will look a whole lot like … [Read more...]

CASE OF THE MONTH:

Feds Net Another Million-Dollar Settlement in 21st Century Oncology FISH Testing Case

AFlorida-based urologist is the latest 21st Century Oncology defendant to fork over seven figures to settle charges of false billing for fluorescence in situ hybridization (FISH) tests. The Original … [Read more...]

NEWS

Diagnostic Deals: A Roundup of January’s Mergers, Acquisitions, Alliances, Licenses and Other Major Transactions

After January's flurry of deals, the M&A front has been relatively quiet so far this month. But relatively low volume of M&A deals has been more than offset by surges in strategic alliances … [Read more...]

NEWS

Industry Newsmaker: Veracyte, Inc. Scores Big with Percepta and Affirma GEC

Veracyte, Inc. is a leader in developing noninvasive genomic diagnostic tests for lung cancer. And in February, Veracyte's share of this lucrative market grew significantly. Percepta Gets Thumbs Up … [Read more...]


(-0000g2)